Latest Content

Navigating the Challenges of Breast Cancer With a Strong Support System

October 16th 2024, 9:00pm

By Darlene Dobkowski, MA

Video

In this on-demand webinar series, CURE partnered with SHARE Cancer Support to learn more about experiences with cancer from two breast cancer survivors.

Next-Generation Imaging a ‘Gold Standard’ in Metastatic Prostate Cancer

October 16th 2024, 7:00pm

By Ashley Chan

Article

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET imaging, an expert explained.

The Uncertainty of Health and Future Plans After a Cancer Diagnosis

October 16th 2024, 5:00pm

By Tamron Little

Article

Receiving a cancer diagnosis can be intimidating, but it’s important to remember that it doesn’t mean you have to stop living.

Treatment for Chemo Mouth May Alleviate Effects from Chemotherapy, Radiotherapy

October 16th 2024, 3:10pm

By Darlene Dobkowski, MA

Article

An oral gel to manage oral mucositis — or chemo mouth — may help alleviate the effects of the side effect related to chemotherapy and radiotherapy.

Fertility Preservation Options for Young Patients With Breast Cancer

October 16th 2024, 1:00pm

By Darlene Dobkowski, MA

Video

An expert discussed options young patients with breast cancer may have to preserve their fertility before starting cancer treatment.

Avastin Regimen Versus Monitoring May Be Beneficial in Cholangiocarcinoma

October 15th 2024, 9:00pm

By Ashley Chan

Article

Patients with gallbladder cancer and cholangiocarcinoma may benefit from receiving Avastin plus Tarceva versus active surveillance.

Why ‘Genetic Testing is Critical’ in Patients with Prostate Cancer

October 15th 2024, 7:00pm

By Alex Biese

Article

As part of the CURE® Educated Patient® Prostate Cancer Summit, an expert discussed the role genetic testing plays in treatment decision-making for many.

International Flat Day, a Breast Cancer Celebration

October 15th 2024, 5:00pm

By Bonnie Annis

Article

When I underwent surgery for breast cancer, reconstruction was highly recommended, but I decided to remain flat — a decision I think about sometimes.

Biomarkers Guide Treatment for Metastatic Breast Cancer

October 15th 2024, 3:00pm

By Darlene Dobkowski, MA

Article

An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.

Keytruda Regimen May Improve Event-Free Survival in Head and Neck Squamous Cell Carcinoma

October 15th 2024, 1:00pm

By Darlene Dobkowski, MA

Article

A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.

Circulating Tumor DNA May Predict Postsurgical Breast Cancer Relapse

October 14th 2024, 9:00pm

By Alex Biese

Article

For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone surgery and chemotherapy.

Transurethral Ultrasound Ablation a Promising Prostate Cancer Treatment

October 14th 2024, 7:00pm

By Spencer Feldman

Article

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

From Survivor to Survivors: Best Wishes for Recovering From a Storm

October 14th 2024, 5:00pm

By Felicia Mitchell

Article

When natural disasters come, they affect everybody, including people dealing with cancer. I hope for speedy recoveries to patients affected by Hurricane Helene.

Understanding Prostate-Specific Antigen (PSA) Testing

October 14th 2024, 4:29pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss how the PSA test is conducted and interpreted, and clarify the definitions of high-risk and advanced prostate cancer types, including their implications for prognosis and subsequent treatment decisions.

When and Why To Get Screened for Prostate Cancer

October 14th 2024, 4:22pm

By Joseph F. Renzulli MD, FACS

Video

Panelists discuss how identifying the right candidates for prostate cancer screening and understanding the role of routine screenings versus symptom-driven assessments are essential for early diagnosis and effective management.